Gimv injects €12.5m into Zorgbedrijven

Enterprise value for Zorgbedrijven remains undisclosed, but Gimv typically seeks companies valued at up to €125m.

The investment was financed via the GP's Health & Care fund, a €200m government-backed vehicle that deploys up to €25m in Benelux-, Germany- and France-headquartered healthcare and medical technology assets.

Following the investment, Zorgbedrijven CEO Jak Dekker and Xpert Clinic founders Thybout Moojen and Reinier Feitz will remain as shareholders in the group.

The injection will finance the company's expansion within the Netherlands, with plans to add new locations to the existing 11 and diversify the therapies currently available in its clinics.

Growth will be sought both organically and via bolt-ons; the latter approach mirrors that of Almaviva Santé, a French private hospital operator owned by Gimv alongside UI Gestion since 2013.

The acquisition, marking the maiden deal for Health & Care Fund, saw the GP continue the build-up strategy set up by previous owner 21 Centrale Partners with the add-on of a Paris hospital in January 2015 and operators Arago and Domus in July 2015.

Company
Equipe Zorgbedrijven was created in 2000. The company's clinics provide hand and wrist surgery via the Xpert brand, while cosmetic surgery and phlebology-related therapies are offered at its Velthuis Kliniek and Helder Kliniek branches.

The business is headquartered in Eindhoven and runs additional offices in Amsterdam, Rotterdam, Enschede, Hilversum, Arnhem, Venlo and Zeis. Its headcount currently sits at 250 employees.

People
Gimv's work on the deal was led by Elderd Land, a partner in the GP's healthcare team. Jak Dekker co-founded Zorgbedrijven and is the group's current CEO.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Benelux
• Expansion
• Healthcare
• Netherlands
• Gimv